AORT insider trading
NYSE HealthcareARTIVION, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ARTIVION, INC.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.
Company website: artivion.com
AORT insider activity at a glance
FilingIQ has scored 564 insider transactions for AORT since Feb 7, 2022. The most recent filing in our index is dated Mar 4, 2026.
Across the full history, 2 open-market purchases
and 254 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on AORT insider trades is 57.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest AORT Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding AORT
Politicians who have traded AORT
Frequently asked
- How many insider trades does FilingIQ track for AORT?
- FilingIQ tracks 564 Form 4 insider transactions for AORT (ARTIVION, INC.), covering filings from Feb 7, 2022 onwards. 36 of those were filed in the last 90 days.
- Are AORT insiders net buyers or net sellers?
- Across the full Form 4 history for AORT, 2 transactions (0%) were open-market purchases and 254 (45%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does AORT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is AORT in?
- ARTIVION, INC. (AORT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.82B.
Methodology & sources
Every AORT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.